跳至主要内容
临床试验/ACTRN12609000104257
ACTRN12609000104257招募中2 期

A randomised controlled trial to study the effectiveness of potent bisphosphonate (Zoledronic Acid) therapy in patients with early osteonecrosis of the hip.

niversity of Sydney/ Northern Clinical School0 个研究点目标入组 120 人开始时间: 2009年2月13日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • symptoms of pain and disability in at least one hip joint and/or positive MRI findings stage I or II on the ARCO classification

排除标准

  • Previous hip joint surgery on the affected hip and/or severe pain and disability at rest if treating clinician has recommended surgery and/or Radiographic or MRI findings suggestive for stage III and IV on the ARCO classification

研究者

发起方
niversity of Sydney/ Northern Clinical School

相似试验